RARA CRAFT DATABASE for FDA Medical Devices
PMAP190031S016

FDA DEVICE FACTS

VENTANA HER2 Dual ISH DNA Probe Cocktail

Ventana Medical Systems, Inc.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEAugust 25, 2026PRODUCT CODENYQ

Indications for use

The VENTANA HER2 Dual ISH DNA Probe Cocktail is intended to determine the HER2 gene amplification status by enumeration of the ratio of the HER2 gene to Chromosome 17 by light microscopy. The HER2 and Chromosome 17 probes are detected using the VENTANA Silver ISH DNP Detection Kit and the VENTANA Red ISH DIG Detection Kit by a two-color chromogenic in situ hybridization (ISH) in formalin-fixed, paraffin-embedded human breast carcinoma and gastroesophageal adenocarcinoma (gastric, gastroesophageal junction and esophageal adenocarcinoma) tissue specimens following staining on a BenchMark ULTRA or BenchMark ULTRA PLUS instrument.

The VENTANA HER2 Dual ISH DNA Probe Cocktail is indicated as an aid in the assessment of patients for whom the following therapies are being considered, in accordance with the approved therapeutic labeling:

• Breast carcinoma patients for whom Herceptin (trastuzumab) or ENHERTU® (fam-trastuzumab deruxtecan-nxki) a is being considered.

• Gastroesophageal adenocarcinomab patients for whom ZIIHERA® (zanidatamab-hrii) in combination with fluoropyrimidine- and platinum-containing chemotherapy and tislelizumab-jsgr is being considered.

a See the ENHERTU® product label for specific clinical circumstances guiding HER2 testing. b Gastroesophageal adenocarcinoma indication is only approved for use with BenchMark ULTRA Instrument.

Test results should be interpreted by a qualified pathologist in conjunction with histological examination, relevant clinical information, and proper controls.

This product is intended for in vitro diagnostic (IVD) use.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: September 30, 2026